Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
Sponsor: The Cleveland Clinic
Terminated
The study was terminated due to lack of feasibility.
Other terminated trials from The Cleveland Clinic
Listed as NCT06426407, this observational or N/A phase trial focuses on Shock, Septic and remains terminated or withdrawn. Sponsored by The Cleveland Clinic, it has been updated 8 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Nov 2025 — Feb 2026 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Aug 2025 — Nov 2025 [monthly]
Not Yet Recruiting
-
Jul 2025 — Aug 2025 [monthly]
Not Yet Recruiting
-
Dec 2024 — Jul 2025 [monthly]
Not Yet Recruiting
▶ Show 3 earlier versions
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The Cleveland Clinic
For direct contact, visit the study record on ClinicalTrials.gov .